Plain-English translation of NCT04846959 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is tracking pregnancies in women who have conditions like psoriasis, psoriatic arthritis, or Crohn's disease. Researchers want to understand whether —a medication approved to treat these conditions—is safe to use during pregnancy and whether it affects the baby. The study will compare outcomes in pregnant women who took this medication to those who took other similar biologic medications.
When women with these chronic conditions become pregnant, they need to know whether their medications are safe for their growing baby. This medication is newer, so there isn't yet enough real-world information about what happens when pregnant women take it. This study will help fill that gap.
You likely qualify if…
You likely don't qualify if…
You would continue seeing your regular doctors for your pregnancy care—this study doesn't require you to take or stop any medications. Your doctors will collect information about your pregnancy, your baby's health, and any side effects during routine visits at your hospital or clinic. The study team will follow you and your baby for up to one year after delivery, tracking how the pregnancy went and how your baby is doing. You may have more visits or paperwork than usual because the study needs detailed health information.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States